| Date | Title | Description |
| 13.07.2026 | Molecular Cytogenetics Market to Reach $1.43 Billion by 2030 | The global molecular cytogenetics market is projected to grow from USD 1.02 billion in 2025 to USD 1.43 billion by 2030, at a CAGR of 7.1% during the forecast period. Market growth is primarily driven by the increasing incidence of cancer a... |
| 21.05.2026 | Daily Stock Market Live
Dow adds nearly 300 points Friday for new record close; S&P 500 notches eighth winning week: Live updates | Stocks rose Friday as Treasury yields eased, resulting in a winning week for Wall Street despite heightened volatility.
The Dow Jones Industrial Average gained 294.04 points, or 0.58%, to end at 50,579.70. The 30-stock index hit an intraday... |
| 16.04.2026 | Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity | Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands:
R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™.
The new brand structure reflects the scientific ... |
| 05.10.2025 | Stock futures are little changed after a record-setting week as government shutdown continues: Live updates | Stock futures were little changed Sunday night as a U.S. government shutdown continued following a week in which Wall Street rallied to record highs.
Dow Jones Industrial Average futures ticked 37 points higher, or 0.1%. S&P 500 futures... |
| 06.08.2025 | ScaleReady 宣布授予优基科技 G-Rex® 资助 圣保罗市，美国明尼苏达州，2025年8月6日 | 优基科技
ScaleReady
ScaleReady 与 Wilson Wolf Manufacturing、Bio-Techne Corporation 和 CellReady 合作，宣布向 Xellera 优基科技 颁发 15万 美元的 G-Rex® 资助，用于建立高效的 cGMP 标准 G-Rex® NK 自然杀伤细胞生产平台。 中华人民共和国香港特别行政区, HONG KONG, August 6, 2025 /EINPresswire.com/ --
ScaleRe... |
| 06.08.2025 | ScaleReady 頒發 G-Rex® 資助予優基科技 , 聖保羅市，美國明尼蘇達州， 2025年8月6日 | 優基科技
ScaleReady
ScaleReady 與 Wilson Wolf Manufacturing、Bio-Techne Corporation 及 CellReady 合作，今日宣布向 優基科技 頒發 15 萬美元的 G-Rex® 資助，以支持建立高效的 cGMP 標準 G-Rex® 為核心的自然殺傷細胞（NK）生產平台 中華人民共和國香港特別行政區, HONG KONG, August 6, 2025 /EINPresswire.com/ --
ScaleRea... |
| 06.08.2025 | ScaleReady Announces a G-Rex® Grant has been awarded to Xellera Therapeutics. ST. PAUL, Minn., 6 August, 2025 | Xellera Therapeutics
ScaleReady
ScaleReady Announces a G-Rex® Grant has awarded US$150K G-Rex® Grant to support Xellera Therapeutics establish a cGMP centric NK cell manufacturing platform. HONG KONG SAR, CHINA, HONG KONG, August 6, 2025 /E... |
| 11.10.2024 | The Future of Protein Research and Gene Editing: A New Era of Innovation | In the world of biotechnology, two upcoming virtual events are set to illuminate the path forward in protein research and gene editing. Bio-Techne and Labroots are leading the charge, showcasing innovations that promise to reshape our under... |
| 09.10.2024 | Bio-Techne Announces "The Simple Way to Advance Protein Research" Virtual Event Series | Bio-Techne 2024 Virtual Event October 24th
Explore the latest innovations in protein research with Bio-Techne's 2024 Virtual Event Series as part of a 12-month campaign to educate and collaborate with members of the biotechnology industry r... |
| 06.09.2024 | Spatial Visualization of Capsid-Dependent Viral Tropism using RNAscope™ ISH Technology, Upcoming Webinar Hosted by Xtalks | www.acdbio.com/science/applications/research-areas/gene-therapy
In this free webinar, explore the cellular tropism of the various adeno-associated virus (AAV) serotypes in a spatial context. Attendees will discover how to detect AAV vector ... |
| 12.08.2024 | Spear Bio: $45 Million (Series A) Raised To Advance Protein Research And Disease Diagnostics | Spear Bio (a biotechnology company enabling the measurement of protein molecules down to dozens of copies with ubiquitous qPCR equipment) announced the closing of its $45 million Series A financing. This oversubscribed round was co-led by F... |
| 07.08.2024 | Morning Bid: BOJ eases market migraine, Super Micro aches | A look at the day ahead in U.S. and global markets from Mike Dolan
In an extraordinary round trip over the past week, world markets have rebounded sharply from days of turbulence - thanks in part to Bank of Japan almost apologising on Wedne... |
| 22.06.2023 | Lunaphore joins the Bio-Techne family | |
| 05.04.2023 | BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA™ INSTRUMENTS NOW IN OPERATION | MINNEAPOLIS, April 5, 2023 /PRNewswire/ -- Bio-Techne Corporation TECH today announced it that it has reached a significant milestone with more than 1,000 Ella™ automated immunoassay instruments now in the field. The achievement is a testam... |
| 04.08.2022 | DIGIT Movers and Shakers | July 2022 | Recruitment Mark Logan
Scotland has officially appointed its first ‘Chief Entrepreneur’, with former Skyscanner executive Mark Logan selected for the role.
The new position has been created specifically to ensure entrepreneurship is “embedd... |
| 15.06.2022 | YCharOS adds Developmental Studies Hybridoma Bank (DSHB) to Industry Advisory Committee | YCharOS continues to expand Industry Advisory Committee and releases new open data
Adding an academic partner shows the strength and flexibility of YCharOS’ open science framework.”
— Dr. Aled EdwardsTORONTO, CANADA, June 15, 2022 /EINPress... |
| 21.03.2022 | YCharOS adds ABclonal Technology to Industry Advisory Committee | YCharOS continues to expand Industry Advisory Committee and releases new open data TORONTO, CANADA, March 21, 2022 /EINPresswire.com/ -- YCharOS Inc., an open science company with the mission of characterizing commercially available antibod... |
| 01.02.2022 | Bio-Techne Corporation announces an Equity Buyback for $400 million worth of its shares. | Bio-Techne Corporation (NasdaqGS:TECH) announces a share repurchase program. Under the program, the company will repurchase up to $400 million worth of its common. |
| 01.02.2022 | BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS | MINNEAPOLIS, Feb. 1, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021.
Second Quarter FY2022 Snapshot
Second quarter organic revenue increased by ... |
| 18.01.2022 | BIO-TECHNE ANNOUNCES COMMERCIAL RELEASE OF HIGH SENSITIVITY FLUORESCENT DETECTION STELLAR NIR / IR™ MODULES FOR JESS AUTOMATED WESTERN BLOTTING SYSTEM | MINNEAPOLIS, Jan. 18, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that ProteinSimple, a Bio-Techne brand, released its Stellar NIR / IR™ Detection Modules for Jess. Stellar fluorescence modules enable detectio... |
| 08.01.2022 | BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE | MINNEAPOLIS, Jan. 7, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, Janua... |
| 05.01.2022 | Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution | MARLBOROUGH, Mass. and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, and Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioact... |
| 27.12.2021 | BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES | MINNEAPOLIS, Dec. 27, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Brenda Everson as Senior Vice President, Human Resources effective January 10, 2022. Ms. Everson succeeds Struan Robertson, ... |
| 21.12.2021 | BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT | MINNEAPOLIS, Dec. 21, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced William A. Geist has been appointed President, Protein Sciences Segment, effective January 3, 2022. Mr. Geist succeeds N. David Eansor, who wil... |
| 14.12.2021 | BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT | MINNEAPOLIS and ST. PAUL, Minn., Dec. 14, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, tod... |
| 08.12.2021 | Bio-Techne Announces Publication of Lateral Flow Technology Proof-of-Concept Data | MINNEAPOLIS, Dec. 8, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the publication of an important manuscript in the journal Scientific Reports, a Nature Research journal, showing proof-of-concept of its proprie... |
| 08.11.2021 | Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis | MINNEAPOLIS, Nov. 8, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Asuragen, Inc., a Bio-Techne brand, has launched a new kit to detect pathogenic variants in the CFTR gene. The AmplideX® PCR/CE CFTR Kit, in... |
| 03.11.2021 | Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility | MINNEAPOLIS, Nov. 3, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the commercial availability of GMP-grade materials manufactured at its St. Paul, MN GMP (Good Manufacturing Practices) manufacturing facility. T... |
| 02.11.2021 | Bio-Techne Releases First Quarter Fiscal 2022 Results | MINNEAPOLIS, Nov. 2, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021.
First Quarter FY2022 Snapshot
First quarter organic revenue increased by 21%... |
| 13.10.2021 | Bio Techne : Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases | MINNEAPOLIS, Oct. 13, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has published important clinical research in the journal Prostate Cancer and Prostatic Diseases, e... |
| 04.10.2021 | EW Healthcare Partners Announces the Promotion of Senior Executives | Oct 04 2021
NEW YORK, New York – EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the promotion of senior executives of their investment team.
• Brooks Andrews has bee... |
| 14.09.2021 | Bio Techne : Launches ExCellerate™ iPSC Expansion Medium | MINNEAPOLIS, Sept. 14, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) Bio-Techne announced the launch of a new medium for the expansion and maintenance of induced pluripotent stem cells (iPSCs) for use in both research and trans... |
| 14.09.2021 | Bio-Techne Launches ExCellerate™ iPSC Expansion Medium | |
| 08.09.2021 | Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis | MINNEAPOLIS and SALT LAKE CITY, Sept. 8, 2021 /PRNewswire/ — Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra Inc., the world lead... |
| 05.08.2021 | Bio Techne : Releases Fourth Quarter Fiscal 2021 Results | MINNEAPOLIS, Aug. 5, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021.
Fourth Quarter FY2021 Snapshot
Fourth quarter organic revenue increased by 39% (... |
| 03.08.2021 | Bio Techne : Announces 2021 Investor Day and Webcast | MINNEAPOLIS, Aug. 3, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host its 2021 Investor Day on Friday, September 10, 2021, starting at 9:00 a.m. EDT. The meeting will take place at the Lot... |
| 03.08.2021 | Bio-Techne Announces 2021 Investor Day and Webcast | |
| 27.07.2021 | Bio Techne : Announces Commercial Release of RNAscope™ HiPlex V2 Assay for Single Cell Validation and Spatial Transcriptomic Profiling of Complex Tissues on FFPE, Fixed and Fresh Frozen Samples. | MINNEAPOLIS, July 27, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope in situ hybridization technology portfolio with the release ... |
| 27.07.2021 | Bio-Techne Announces Commercial Release of RNAscope™ HiPlex V2 Assay for Single Cell Validation and Spatial Transcriptomic Profiling of Complex Tissues on FFPE, Fixed and Fresh Frozen Samples. | |
| 28.06.2021 | Bio techne : Announces Opening Of New Ireland Facility | MINNEAPOLIS, June 28, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the opening of its new Ireland facility located in Dublin. This new facility reflects Bio-Techne's commitment to supporting the broader life sci... |
| 24.06.2021 | Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies | |
| 18.05.2021 | Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications | |
| 18.05.2021 | BIO-TECHNE CORPORATION
Bio Techne : and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications | MINNEAPOLIS, May 18, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a collaboration with Narayana Nethralaya to develop a diagnostic solution for ophthalmology disorders on its ProteinSimple branded, multiplexing... |
| 06.05.2021 | Bio Techne : Releases Third Quarter Fiscal 2021 Results | MINNEAPOLIS, May 6, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021.
Third Quarter FY2021 Snapshot
Third quarter organic revenue increased by 22% (25%... |
| 27.04.2021 | Bio-Techne Announces Commercial Release of Novel DNAscope™ in situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations | |
| 27.04.2021 | BIO-TECHNE CORPORATION
Bio Techne : Announces Commercial Release of Novel DNAscope™ in situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations | MINNEAPOLIS, April 27, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope™ technology with release of new DNAscope Assays. The RNAscop... |
| 15.04.2021 | Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis | |
| 15.04.2021 | BIO-TECHNE CORPORATION
Bio Techne : Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis | MINNEAPOLIS, April 15, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in response to increased demand for its Ass... |
| 14.04.2021 | Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development | |
| 14.04.2021 | BIO-TECHNE CORPORATION
Bio Techne : Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development | MINNEAPOLIS, April 14, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a license agreement for use of a proprietary Bio-Techne antibody by Xencor, Inc., a clinical-stage biopharmaceutical company developing engine... |
| 08.04.2021 | Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess | |
| 08.04.2021 | BIO-TECHNE CORPORATION
Bio Techne : Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess | MINNEAPOLIS, April 8, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that ProteinSimple, a Bio-Techne brand, released Abby, its next generation chemiluminescence system that automates traditional Western blotting.... |
| 29.03.2021 | Bio-Techne Announces Launch of Cultrex UltiMatrix BME to Support Organoid and Pluripotent Stem Cell Cultures | |
| 29.03.2021 | BIO-TECHNE CORPORATION
Bio Techne : Announces Launch of Cultrex UltiMatrix BME to Support Organoid and Pluripotent Stem Cell Cultures | MINNEAPOLIS, March 29, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of Cultrex™ UltiMatrix™ Reduced Growth Factor Basement Membrane Extract (RGF BME), an extracellular matrix hydrogel that provides ... |
| 26.03.2021 | Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb | |
| 26.03.2021 | BIO-TECHNE CORPORATION
Bio Techne : Announces Receipt of COVID-19 Innovation Award from CiteAb | MINNEAPOLIS, March 26, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its R&D Systems and Novus brands have been named winners of the CiteAb COVID-19 Innovation Award. This award celebrates innovative so... |
| 23.03.2021 | Bio-Techne's Exosome Diagnostics Laboratory Announces CE-IVD Certification For ExoDx Prostate Test | |
| 15.03.2021 | Bio-Techne Announces ISO 9001:2015 Certification for its Bristol Manufacturing Facility. | |
| 10.03.2021 | Mount Sinai Venture Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021 | NEW YORK (PRWEB) March 10, 2021
Mount Sinai Health System announced today that Kantaro Biosciences, LLC, a joint venture with RenalytixAI, has been named to Fast Company’s prestigious annual list of the “World’s Most Innovative Companies” f... |
| 08.03.2021 | Bio-Techne Announces ExoTRU Kidney Transplant Rejection Assay Data Publication | |
| 11.02.2021 | Bio-Techne Announces Paper Publication In Annals Of Oncology | |
| 03.02.2021 | Bio-Techne Announces Expanded Simple Plex Immunoassay Cartridge Portfolio | |
| 28.01.2021 | Bio-Techne Announces Strategic Investment In Eminence | |
| 08.09.2020 | Bio-Techne And Hall Of Famer Cal Ripken Jr -Announce Partnership To Raise Awareness And Education To Empower Men With Prostate Cancer | |
| 13.12.2019 | TELA Bio Announces Closing of Initial Public Offering of Common Stock | Dec 13 2019
MALVERN, Pennsylvania—TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs ... |
| 06.12.2019 | TELA Bio Awarded Contract with HealthTrust Purchasing Group | Dec 06 2019
MALVERN, Pennsylvania—TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs ... |
| 26.06.2019 | TissueTech Raises $82 Million in Latest Round of Equity Financing | Jun 26 2019
EW Healthcare Partners Managing Director Martin Sutter and Former Medtronic CEO Bill Hawkins join TissueTech Board of Directors
(PRWEB) MIAMI, Florida—TissueTech, Inc., the pioneer in regenerative medicine utilizing human umbi... |
| 14.11.2014 | Bio-Techne Acquires CyVek for $60M | Bio-Techne (NASDAQ:TECH), a Minneapolis, MN-based company engaged in the development, manufacture and sale of biotechnology products and clinical calibrators and controls, completed the acquisition of CyVek, a Wallingford, CT-based develope... |
| 26.08.2014 | MRC Technology negotiates licence with Bio-Techne for GOPAL protein synthesis technology | MRC Technology negotiates licence with Bio-Techne for GOPAL protein synthesis technology
26-08-2014
MRC Technology, a technology transfer organisation, today announced it has negotiated a licence for a protein synthesis technology, Genetica... |
| 18.07.2011 | Cell Biosciences Changes Name to ProteinSimple | Jul 18 2011
SANTA CLARA, California— Cell Biosciences, Inc. today announced that it has changed its name to ProteinSimple to clearly reflect the Company’s core mission in protein research.
The Company’s goal is simply to help researchers ... |
| 03.02.2011 | Corium International Adds Dr. Bhaskar Chaudhuri and David Greenwood to Board of Directors | Feb 03 2011
MENLO PARK, California – Corium International, Inc., a privately-held advanced transdermal drug delivery company, today announced the appointment of Dr. Bhaskar Chaudhuri and David L. Greenwood to the Board of Directors. Dr. Ch... |
| - | Bio Techne : Multisite Study Demonstrates Utility of Asuragen Kit for Identifying Variants Linked to Spinal Muscular Atrophy | MINNEAPOLIS, May 10, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Asuragen, a Bio-Techne brand, and scientific collaborators have published the results of a multisite evaluation study of the AmplideX® PCR/C... |
